3,605
Views
112
CrossRef citations to date
0
Altmetric
Original Research

Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

, , , , , , , , , , , , , , , , , , , , & show all
Article: e1129483 | Received 28 Oct 2015, Accepted 30 Nov 2015, Published online: 31 May 2016

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.